← All trials
NCT04911621
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 10, 2021
- Primary completion
- Jun 1, 2027
- Completion date
- Jun 1, 2027
- First posted
- Jun 3, 2021
- Last posted
- Sep 20, 2021
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of AntwerpLead sponsor
- University of AntwerpOverall official - principal investigator
- Kom Op Tegen KankerCollaborator
- Olivia Hendrickx research Fund vzwCollaborator
- Stichting SemmyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.